Frequencies for first 10,000 rows of lit_ref variable in demo2016q2 dataset : Literature Reference | Freq. Percent Cum. ----------------------------------------+----------------------------------- | 9,488 94.88 94.88 ( | 1 0.01 94.89 , 0000 , , , , | 1 0.01 94.90 , ANDERSSON B, GUSTAFSSON F, EISKJAER.. | 1 0.01 94.91 , ARLINGHAUS L, CARDIN D, GOFF L, BER.. | 1 0.01 94.92 , BARDAJI A, MACETE E, NHAMPOSSA T, F.. | 1 0.01 94.93 , BEIER R, ORJUELA-GRIMM M, SCHOBER T.. | 1 0.01 94.94 , CALLANAN D, WILLIAMS P, ANDERSON L,.. | 1 0.01 94.95 , DISTLER J, MAURER B, HUSCHER D, VAN.. | 1 0.01 94.96 , FOUQUES H, MAIGNE G, JOHNSON H, CHA.. | 1 0.01 94.97 , FOURRIER-REGLAT A, SMITH D, BECOUAR.. | 1 0.01 94.98 , GOLDSCHMIDT N, BAIREY O, RUCHLEMER .. | 1 0.01 94.99 , GOLDSCHMIDT N, BAIREY O, RUCHLEMER .. | 2 0.02 95.01 , GOLDSCHMIDT N, BAIREY O, RUCHLEMER .. | 4 0.04 95.05 , HAUGE P, WARLOE T, DROLSUM A, JOHAN.. | 1 0.01 95.06 , HILL M, POPPE A, BUCHAN A AND COUTT.. | 1 0.01 95.07 , HUANG R, YU X, LIU Y AND GAO Y. IS .. | 1 0.01 95.08 , JAEGER U, PETZER A, WILLENBACHER W,.. | 1 0.01 95.09 , KAMON T, KAJIKAWA H, KITAGAWA T AND.. | 1 0.01 95.10 , KARAYAMA M, INUI NAOKI, KUROISHI S,.. | 1 0.01 95.11 , KEATING M, O^BRIEN S, WIERDA W, JAI.. | 1 0.01 95.12 , LOKKEN T, HELLAND A, NORDRUM I AND .. | 1 0.01 95.13 , MITSUHASHI R, IWASAKI T, GOTO H AND.. | 1 0.01 95.14 , MORTIMER J, YUAN Y, JUNG J, KRUPER .. | 2 0.02 95.16 , MOTTA VENCHIARUTTI M, RACHEL R, KIC.. | 1 0.01 95.17 , NOGAMI N, KITAJIMA H, IWASAWA S, SA.. | 1 0.01 95.18 , NUNES F, COHEN D, XIE W, MARINCIC C.. | 1 0.01 95.19 , OGIMI TAKASHI, NITTA MIHO, ET AL. P.. | 1 0.01 95.20 , O^REGAN R, XU B, MASUDA N, ARENA F,.. | 1 0.01 95.21 , PIRIS-VILLAESPESA M, DALIA S, POWER.. | 1 0.01 95.22 , REDD R, ARMAND P, BANWAIT R, BOSWEL.. | 1 0.01 95.23 , RENFRO L, CHOW O, SHI Q, CARRERO X,.. | 1 0.01 95.24 , SISK R, TZU J, ALBINI T, DAVIS J, M.. | 1 0.01 95.25 , SISK R, TZU J, ALBINI T, DAVIS J, M.. | 1 0.01 95.26 , STINGO F, KEATING M, FERRAJOLI A, B.. | 1 0.01 95.27 , UEDA RIE, FUKUI EIJI, ET AL. A PATI.. | 1 0.01 95.28 , VAN WERKHOVEN E, MANDJES I, SCHOT M.. | 1 0.01 95.29 , YAMAKAWA K, ONISHI M, ET A BRIEF CA.. | 1 0.01 95.30 , YOTHERS G, O^CONNELL M, BEART R, WO.. | 1 0.01 95.31 , YOUNOSSI Z, STEPANOVA M, POL S, BRO.. | 1 0.01 95.32 , YUAN Y, JUNG J, KRUPER L, STEWART D.. | 1 0.01 95.33 , YUAN Y, JUNG J, KRUPER L, STEWART D.. | 1 0.01 95.34 , YUAN Y, JUNG J, KRUPER L, STEWART D.. | 1 0.01 95.35 , YUAN Y, JUNG J, KRUPER L, STEWART D.. | 1 0.01 95.36 , YUAN Y, JUNG J, KRUPER L, STEWART D.. | 1 0.01 95.37 . . ;:-. | 1 0.01 95.38 A. AMIOT, J-C GRIMAUD, L. PEYRIN-BIRO.. | 1 0.01 95.39 A. AMIOT, J.-C. GRIMAUD, L. PEYRIN-BI.. | 2 0.02 95.41 AARON M. SAFETY AND TOLERABILITY OF C.. | 1 0.01 95.42 AARTS MJ, PETERS FP, MANDIGERS CM, DE.. | 1 0.01 95.43 ABD-EL-MONEIM S, WELAYA KY, EL-ASSAL .. | 1 0.01 95.44 ACCORINTI M, PESCI FR, PIRRAGLIA MP, .. | 1 0.01 95.45 AL MAASHARI R, HAMODAT M. METHOTREXAT.. | 1 0.01 95.46 AL-ABRI S. ET AL. CARDIOGENIC SHOCK: .. | 1 0.01 95.47 AL-ABRI SA, THOREN KL, BENOWITZ NL. M.. | 1 0.01 95.48 AL-ASSI D, ARIF F, HORTON M, BAKER D,.. | 1 0.01 95.49 AMI N. TWO CASES O F PREGNANCY COMPL.. | 1 0.01 95.50 ANONG J, LITCHFIELD J, BAJAJ K. FRIEN.. | 1 0.01 95.51 APLASTIC ANAEMIA SYMPOSIUM (MIELPARQUE) | 1 0.01 95.52 APLASTIC ANEMIA SYMPOSIUM (MIELPARQUE.. | 1 0.01 95.53 ARCAS RM, JIMENEZ GE, ZAMORA CP. CA.. | 1 0.01 95.54 ARCINIEGAS DB, ANDERSON CA. DONEPEZIL.. | 1 0.01 95.55 ARORA S, PATEL R, FADILA M, WOOL K. T.. | 1 0.01 95.56 ARORA, S.. KOUNIS SYNDROME-THE ALLERG.. | 1 0.01 95.57 ATIQ O, ABRAMS G. NSAIDS-INDUCED COLO.. | 1 0.01 95.58 BALDASSANO R, RUEMMELE F, ROSH J, FAU.. | 1 0.01 95.59 BALKO JA, HYNAN LS, ATTAR N, SANDERS .. | 1 0.01 95.60 BANGSGAARD N. SENSITIZATION TO AND AL.. | 1 0.01 95.61 BARMAN SL, JEAN GW, DINSFRIEND WM, GE.. | 1 0.01 95.62 BASCOM P, BORDLEY J, LAWTON A. HIGH-D.. | 1 0.01 95.63 BELTRAN PAPSDORF TB, SHIN HW, CHAHIN .. | 1 0.01 95.64 BERSVENDSEN H, KOLSTAD A, BLYSTAD A, .. | 1 0.01 95.65 BERSVENDSEN H. MULTIMODAL TREATMENT W.. | 1 0.01 95.66 BETTGE AM, GROSS GN. A SERUM SICKNESS.. | 1 0.01 95.67 BHAT ZY, REDDY S, PILLAI U, DOSHI M, .. | 1 0.01 95.68 BIARY R, HOWLAND MA, SMITH SW, HOFFMA.. | 1 0.01 95.69 BIBAULT J, CAMBIER N, LEMAHIEU J, QUE.. | 1 0.01 95.70 BICHOUPAN K, BELLO DD, YALAMANCHILIL .. | 1 0.01 95.71 BOGA S,JAIN D,SCHILSKY M. TRIENTINE I.. | 1 0.01 95.72 BOTCH-JONES SR, JOHNSON R, KLEINSCHMI.. | 1 0.01 95.73 C.TONG, Z.HUSSEIN, N.MOHD NOOR, ET.AL.. | 1 0.01 95.74 CAMERON FL, WILSON ML, BASHEER N, JAM.. | 1 0.01 95.75 CANTRELL FL, MENA O, GARY RD, MCINTYR.. | 1 0.01 95.76 CANTRELL, F.L.. AN ACUTE GABAPENTIN F.. | 1 0.01 95.77 CAPALDI VF 2ND, CARR RB. CITALOPRAM-I.. | 3 0.03 95.80 CAPALDI VF II, CARR RB. CITALOPRAM-IN.. | 3 0.03 95.83 CAROLEO, B.. REACTIVATION OF CHRONIC .. | 1 0.01 95.84 CHE C, BODIN R, WOLF D. TRAZODONE AND.. | 1 0.01 95.85 CHEN S, AI C, WANG X, DAI W. EFFECT .. | 1 0.01 95.86 CHIEFFO G, PAGNUCCO L, GULMINETTI R, .. | 1 0.01 95.87 CHINTAKUNTLAWAR A,KIDD M,AL-KALI A,WI.. | 1 0.01 95.88 CHIOU L, TAN T, WU M, KU W, CHEN W. T.. | 1 0.01 95.89 CHOW TW, LINKS KA, MASTERMAN DL, MEND.. | 1 0.01 95.90 CHRISTIAN MR, KLEM SA, LOWRY JA. GARG.. | 1 0.01 95.91 CLAYTON R, HENG DY, WU JS, ZIELINSKI .. | 1 0.01 95.92 CLOWSE, M.. PREGNANCY OUTCOMES IN THE.. | 1 0.01 95.93 CLOWSE. PREGNANCY OUTCOMES IN THE TOF.. | 1 0.01 95.94 COIFFIER B, THIEBLEMONT C, DE GUIBERT.. | 1 0.01 95.95 COLANTONIO D, WALSH W, THOMPSON M, VE.. | 1 0.01 95.96 COLLYER E, KAY M. RESPONSE TO FONTANA.. | 1 0.01 95.97 CRITTENDEN N, DAVIS EG, MARSANO LS, M.. | 1 0.01 95.98 DAQUAN G. RETROSPEAIVE STUDY OF INTRA.. | 1 0.01 95.99 DATTA ANITA, BELLO-ESPINOSA L, SCANTL.. | 1 0.01 96.00 DE CLERCK F, DE WILDE V, ORLENT H, LO.. | 1 0.01 96.01 DELROSSO L, GONZALEZ-TOLEDO E, CHESSO.. | 1 0.01 96.02 DEVOGELAER JP, LECOUVET F, DEPRESSEUX.. | 1 0.01 96.03 DICKEY, S.. POSSIBLE SULFAMETHOXAZOLE.. | 1 0.01 96.04 DO NOT LET ^DEPO-^ MEDICATIONS BE A D.. | 1 0.01 96.05 DOAN VP, GULBIS A, YEH J, AHMED S, AR.. | 1 0.01 96.06 DOBKOWSKI D. AN OLDER MAN WITH GOUT A.. | 1 0.01 96.07 DOHIL, R., FILDER, M., BARSHOP, B., N.. | 1 0.01 96.08 DRINKWATER B, BILLYARD T. EFFECT OF I.. | 1 0.01 96.09 DULGEROGLU ERDOGDU D, BAL A, KARAAHME.. | 1 0.01 96.10 DUNN AL, REED T, STEWART C, LEVY RA. .. | 1 0.01 96.11 DURAND DF, MARIGNIER R, BENOIT A, R.. | 1 0.01 96.12 DURON C, GOUTTE M, PEREIRA B, BUISSON.. | 1 0.01 96.13 EITEL I, WOHRLE J, SUENKEL H, MEISS.. | 1 0.01 96.14 ELIZABETH GW, MAHIR P, KATHERINE H, A.. | 1 0.01 96.15 ENOMOTO S,KAMISAWA T,YAMAZAKI N,TAKAH.. | 1 0.01 96.16 ENOMOTO S,KAMIZAWA Y,KAMISAWA T,YAMAZ.. | 1 0.01 96.17 ENOMOTO S,KAMIZAWA Y,KAMISAWA T,YAMAZ.. | 2 0.02 96.19 ENOMOTO S,KAMIZAWA Y,KAMISAWA T,YAMAZ.. | 1 0.01 96.20 ENOMOTO S,KAMIZAWA Y,KAMIZAWA T,YAMAZ.. | 1 0.01 96.21 ERYILMAZ G,ENEZ DARCIN A,SAGLAM E,GOG.. | 1 0.01 96.22 FALLON M, HECK J. FATAL STEVENS-JOHNS.. | 1 0.01 96.23 FAN KY, CHEN WY, HUANG MC. QUETIAPINE.. | 2 0.02 96.25 FEAGAN BG, MCDONALD JW, PANACCIONE R,.. | 1 0.01 96.26 FELIX MJP, FELIPE CR, TEDESCO-SILVA H.. | 1 0.01 96.27 FENG J, WU J, SONG Y, SU L, ZHANG M, .. | 1 0.01 96.28 FERFOGLIA R, VIALA K, NICOLAS G, CREA.. | 1 0.01 96.29 FONTAINE H, ET.AL.. CARDIAC ARRHYTHMI.. | 1 0.01 96.30 FONTAINE H, LAZARUS A, PERIAUX C, BAG.. | 1 0.01 96.31 FORD RM, PILLAI A, CHENG N, YOUNG NM,.. | 1 0.01 96.32 FRANCO J, VALLABHAJOSYULA S, GRIFFIN .. | 1 0.01 96.33 FRANCO J, VALLABHAJOSYULA S, GRIFFIN .. | 1 0.01 96.34 FRANCO JM, VALLABHAJOSYULA S, GRIFFIN.. | 1 0.01 96.35 FRANKM MICHAEL L. THE USE OF PREOPERA.. | 1 0.01 96.36 FREDERIC C, LAURENCE G, PAULINE G, MA.. | 1 0.01 96.37 FRENCH, D.. RETROSPECTIVE DETERMINATI.. | 1 0.01 96.38 FREW J. PSYCHOPHARMACOLOGY OF BIPOLAR.. | 1 0.01 96.39 FRIDRIK MA, PETZER A, WILLENBACHER W,.. | 1 0.01 96.40 FUDIN J, FONTENELLE DV, PAYNE A. RIFA.. | 1 0.01 96.41 FULMINANT MYOCARDITIS WITH ACUTE CARD.. | 1 0.01 96.42 FUNG, ELW AND NELSON, EAS. OLIGOHYDRO.. | 1 0.01 96.43 G.ANDROUTSOPOULOS, K. TSIVERIOTIS, V... | 1 0.01 96.44 GAIES E, BEN SASSI M, CHARFI R, LAKHA.. | 1 0.01 96.45 GALLEGO A, ALVARADO E, GELY C, PAGES .. | 1 0.01 96.46 GEISSLER K, JAGER E, BARNA3 A, SIWA .. | 1 0.01 96.47 GERRIE AS, MIKHAEL JR, CHENG L, JIANG.. | 1 0.01 96.48 GIL M, BELLET C, LLOMBART A, OJEDA B,.. | 1 0.01 96.49 GIRAY B, KARSIDAG AYK, BUYUKBAYRAK EE.. | 2 0.02 96.51 GIUSTINIANO E, MECO M, EMANUELA M, RU.. | 5 0.05 96.56 GIVEN J, TAVERAS H, IVERSON H. PROSPE.. | 1 0.01 96.57 GLADKOV O, ELSAESSER R, BUCHNER A, BI.. | 1 0.01 96.58 GLUECK CJ, FRIEDMAN J, HAFEEZ A, HASS.. | 1 0.01 96.59 GOLDZWEIG O, CARRASCO R, HASHKES PJ. .. | 1 0.01 96.60 GOTO M. A CASE OF A PATIENT WHO EXPER.. | 1 0.01 96.61 GROVER CA, WIELE ED, CLOSE RJ. NARCOT.. | 1 0.01 96.62 GRUNBAUM AM, KAZIM S, GHANNOUM M, KAL.. | 1 0.01 96.63 GUTIERREZ JA, GRIGORIAN A, CARRION AF.. | 1 0.01 96.64 HALLIDAY ML, BOYD M, MORGAN BW. ACIDO.. | 1 0.01 96.65 HAMADA, F.. A CASE OF INTRACRANIAL HA.. | 1 0.01 96.66 HAMASAKI H, HAKOSHIMA M, YANAI H. PER.. | 3 0.03 96.69 HANSEN L, CECERE S, THOGERSEN T. SEVE.. | 1 0.01 96.70 HARA K ET AL.. A CASE OF EUGLYCEMIC D.. | 1 0.01 96.71 HARADA R, SUZUKI H, KUBOTA W, HASHIMO.. | 1 0.01 96.72 HASAN A, LOCKE A, LITCHFIELD J, MCKIN.. | 1 0.01 96.73 HASEGAWA, J.. A CASE OF RHEUMATOID AR.. | 1 0.01 96.74 HATANAKA. PROGRAM AND ABSTRACTS OF TH.. | 1 0.01 96.75 HAYES MJ, ADAM SC, SAKURABA A. COMPAR.. | 1 0.01 96.76 HE XL. ECG ANALYSIS OF TAKING OLANZAP.. | 1 0.01 96.77 HEISE CW, BEUTLER D, BOSAK A, ORME G,.. | 1 0.01 96.78 HEISE CW, ET AL.. ATENOLOL/CHLORTALID.. | 1 0.01 96.79 HIROAKI TAMURA, ET AL.. AMLODIPINE BE.. | 1 0.01 96.80 HIROAKI TAMURA. AMLODIPINE HYDROCHLOR.. | 1 0.01 96.81 HUMAYUN Y, BALL KC, LEWIN JR, LERANT .. | 1 0.01 96.82 HUNAULT M, MAILLARD N, TANGUY-SCHMIDT.. | 1 0.01 96.83 IINUMA S, HORI M, HAYASHI, K, KANNO K.. | 1 0.01 96.84 IIO H. EXPERIENCE WITH THE USE OF ENZ.. | 1 0.01 96.85 IKEGAKI H ET AL. THE JAPANESE JOURNAL.. | 1 0.01 96.86 IKUMI K, FUKUOKA M, MORITA A. A CASE .. | 1 0.01 96.87 INANC M, AKPEK M, INANC MT, KAYA MG. .. | 1 0.01 96.88 INDRACCOLO S, RANDON G, ZULATO E, NAR.. | 1 0.01 96.89 ISHIKAWA N. IMMUNOSUPPRESSIVE PROTOCO.. | 1 0.01 96.90 ISKANDAR J, VANCE J, KABLINGER A, KAV.. | 1 0.01 96.91 ITAYA S, SUZUKI M, HORI T, AKAZA M, K.. | 1 0.01 96.92 IWERSEN-BERGMANN S, JUNGEN H, ANDRESE.. | 4 0.04 96.96 JAIN D. FERTILITY AND PREGNANCY OUTCO.. | 1 0.01 96.97 JANG H, KIM J, CHOI S, YOON Y, MOON S.. | 1 0.01 96.98 JARDIN CG, PUTNEY D, MICHAUD S. ASSES.. | 1 0.01 96.99 JAYABOSE S, RATHNAM K, KASI V, KUMAR .. | 1 0.01 97.00 JINNUR P, VASUDEVAN V, ALI R, ARJOMAN.. | 1 0.01 97.01 JONES J, PAWLYN C, BRIOLI A, CAIRNS D.. | 1 0.01 97.02 JOSE BASELGA ET AL. PHASE II RANDOMIZ.. | 1 0.01 97.03 JOSEPH YH, DIXON SN, REISS JP, WALD .. | 1 0.01 97.04 JUAN CARLOS Q VELEZ. RENAL THROMBOTIC.. | 1 0.01 97.05 JURRLINK, DN. POSTPARTUM MATERNAL COD.. | 1 0.01 97.06 KAICHI NISHIWAKI. TWO CASES OF CEREBR.. | 2 0.02 97.08 KAKUDA T, MIURA N, FUKUMOTO T, YANAGI.. | 1 0.01 97.09 KAKUTA T, MIURA N, FUKUMOTO T, YANAGI.. | 1 0.01 97.10 KAMEDA T, DOBASHI H, MIYATAKE N, INOO.. | 3 0.03 97.13 KAMOI K. EARLY EXPERIENCES WITH NEW A.. | 1 0.01 97.14 KANDULA S, BURKE WS, GOLDFARB JN. CLI.. | 1 0.01 97.15 KAPILA A, CHHABRA L, LOCKE A D, PATEL.. | 1 0.01 97.16 KAPILA A, CHHABRA L, LOCKE A, PATEL P.. | 1 0.01 97.17 KARA K, KARA H, KARAMAN D, DURUKAN I,.. | 1 0.01 97.18 KASHIWAGUMA D, KAWASHIMA H, TAKAHASHI.. | 1 0.01 97.19 KATAOKA M, YANAGISAWA R, YOSHINO H, S.. | 1 0.01 97.20 KATSOULIS I,NASIKAS D,KALOGIRATOU E,A.. | 1 0.01 97.21 KATSUMITSU A, ET AL. EFFECTIVE CASES .. | 1 0.01 97.22 KENEALY M, SEYMOUR J, BENSON W, STEVE.. | 1 0.01 97.23 KENSUKE WADA AT ET AL.,. A CASE OF IN.. | 1 0.01 97.24 KERDSIRICHAIRAT T, LAKE J. RESCUE THE.. | 2 0.02 97.26 KETTERER N, COIFFIER B, THIEBLEMONT C.. | 1 0.01 97.27 KILICOGLU AG, IPEK H, MUTLU C, DOGAN .. | 1 0.01 97.28 KIM HK, HOFFMAN RS, NELSON LS, JANG D.. | 1 0.01 97.29 KIM SJ. MULTICENTER PHASE II STUDY OF.. | 1 0.01 97.30 KIM SJ.. MULTICENTER PHASE II STUDY O.. | 1 0.01 97.31 KIM, H-J.. OXALIPLATIN-INDUCED TORSAD.. | 1 0.01 97.32 KLEINSASSER NH. BISPHOSPHONATE INDUCE.. | 1 0.01 97.33 KLEINSASSER NH. BISPHOSPHONATE INDUCE.. | 1 0.01 97.34 KOBAYASHI M, YAMASHITA H, KANEKO S, U.. | 1 0.01 97.35 KOUNIS NG, KOUNIS GN, SOUFRAS GD, TSI.. | 1 0.01 97.36 KUCINSKIENE V, VILKICKAITE V, MAKSTIE.. | 1 0.01 97.37 KUSUDA Y. USE EXPERIENCE OF ABIRATERO.. | 1 0.01 97.38 KWAK C, LIN WU TT, LEE HM, WU HC, HON.. | 1 0.01 97.39 KWAN BYM, KRINGS T, BERNSTEIN M, MAND.. | 1 0.01 97.40 KYOKO I, MURAMATSU S, KUBO R, MURASHI.. | 1 0.01 97.41 LAEMMLE A, HAHN D, HU L, RUFENACHT V,.. | 1 0.01 97.42 LAES J, OROZCO BS, COLE JB. USE OF PE.. | 1 0.01 97.43 LASALA GS, VEARRIER D, GREENBERG MI. .. | 1 0.01 97.44 LAURITZSEN G, BERVENDSEN H, KOLSTAD A.. | 2 0.02 97.46 LEE H,RUGGOO V,GRAUDINS A. INTRATHECA.. | 1 0.01 97.47 LEE HM, RUGGOO V, GRAUDINS A.. INTRAT.. | 1 0.01 97.48 LEE HMD, RUGGOO V, GRAUDINS A. INTRAT.. | 1 0.01 97.49 LEE SKK, APPLEMANS E, THORNTON J, BRE.. | 1 0.01 97.50 LEE, S.. DELAYED DIAGNOSIS OF CHOLEST.. | 1 0.01 97.51 LEWIS WE, BRAHM N, NICOLE WB. PILOT S.. | 1 0.01 97.52 LEWIS WE, BRAHM N, WASHINGTON NB. PIL.. | 1 0.01 97.53 LIAN W. EFFICACY OBSERVATION AND CARE.. | 1 0.01 97.54 LICHTMAN SM, CIRRINCIONE C, HURRIA A.. | 1 0.01 97.55 LIU J. ITRACONAZOLE (ICZ) AND ANPHOTE.. | 1 0.01 97.56 LIU SV, TSAO-WEI DD, XIONG S, GROSHEN.. | 1 0.01 97.57 LOSCO G, STUDD R, BLACKMORE T. ERTAPE.. | 1 0.01 97.58 LYONS JL, COHEN AB. SELECTIVE CEREBEL.. | 1 0.01 97.59 MACDONALD D, VAN DER JAGT R, BURKE JM.. | 1 0.01 97.60 MACHT M, MULL AC, MCVANEY KE, CARUSO .. | 1 0.01 97.61 MAFFEI R, MARTINELLI S, DEBBIA G, RIG.. | 1 0.01 97.62 MAFFEI R, MARTINELLI S, DEBBIA G, RIG.. | 1 0.01 97.63 MAHARAJ AB, CHANDRAN V. PANCYTOPENIA .. | 1 0.01 97.64 MARCHESE R, GURTMAN A, OSTERHOUDT KC,.. | 1 0.01 97.65 MARRAFFA JM, HOLLAND MG, SULLIVAN RW,.. | 2 0.02 97.67 MARRAFFA JM, HOLLAND MG, SULLIVAN RW,.. | 1 0.01 97.68 MASASHI FUKUSHIMA, ET AL. SPRUELIKE E.. | 1 0.01 97.69 MATSUNAGA N, KITAHARA T, MORIZUKA A, .. | 1 0.01 97.70 MATSUZAWA N. O-74 A CASE OF NEUTROPHI.. | 1 0.01 97.71 MCMEEKIN D, SILL MW, WALKER JL, MOORE.. | 1 0.01 97.72 MENDES D, ALVES C, MARQUES FB. SAFETY.. | 1 0.01 97.73 MINAMI N, YAMADA S, HONZAWA Y, MATS.. | 1 0.01 97.74 MINAMI N, YAMADA S, HONZAWA Y, MATSUM.. | 1 0.01 97.75 MIYAMURA M,ICHIHARA N,YAMAUCHI Y,NOMU.. | 1 0.01 97.76 MOCHIZUKI T, IGARASHI M, FUKUYA Y, KA.. | 1 0.01 97.77 MOFFETT BS, VALDES SO, KIM JJ. POSSIB.. | 1 0.01 97.78 MOLTENIS M, BELIN N, PATRY C, HUGOT .. | 1 0.01 97.79 MORI M, KIM HM, IKEDA M, OKANO M, MIY.. | 1 0.01 97.80 MORIARTY B, LAMB R, DURACK A, MAY C, .. | 1 0.01 97.81 MORIWAKI K,KIMURA Y,WATABE N,MISAO N,.. | 1 0.01 97.82 MORIWAKI K,KIMURA Y,WATABE N,MISAO N,.. | 1 0.01 97.83 MOURAO AF, SANTOS MJ, MELO GOMES JA, .. | 1 0.01 97.84 MOWRY J B, SPYKER D A, CANTILENA J R,.. | 1 0.01 97.85 MOY B, KAPILA N. PROBABLE DOXYCYCLINE.. | 1 0.01 97.86 MOY B,KAPILA N. PROBABLE DOXYCYCLINE-.. | 1 0.01 97.87 MOY BT, KAPILA N.. PROBABLE DOXYCYCLI.. | 1 0.01 97.88 MOY, B.. PROBABLE DOXYCYCLINE-INDUCED.. | 1 0.01 97.89 MRVOS R, PUMMER TL, KRENZELOK EP. AMO.. | 2 0.02 97.91 MRVOS R, PUMMER TL, KRENZELOK EP. AMO.. | 3 0.03 97.94 MUKAI W, MUKAI W, AKIYAMA T, SAEKI I,.. | 1 0.01 97.95 MULAY S, BORUCHOV A. RECURRENT AND PA.. | 1 0.01 97.96 MULDER M, BERKHEMER O, FRANSEN P, BEU.. | 1 0.01 97.97 MUNOZ DE BUSTILLO E, IBARROLA C, ANDR.. | 1 0.01 97.98 MUTO I, ET AL.. A CASE OF REFRACTORY .. | 1 0.01 97.99 MYA D. RISK OF HEPATITIS B REACTIVATI.. | 1 0.01 98.00 NA A, HALL N, KAVAR B, KING J. CENTRA.. | 1 0.01 98.01 NAGASHIMA A. TWO CASES O F PREGNANCY .. | 1 0.01 98.02 NAKAMURA H, MIYAUCHI A, MIYAWAKI N, I.. | 1 0.01 98.03 NAKATANI T | 1 0.01 98.04 NANDIKANTI D,GOSMANOVA E,GOSMANOV A. .. | 1 0.01 98.05 NAWROCKA I, KOWALCZYS MH, ABRAMCZYK P.. | 1 0.01 98.06 NAWROCKA I,KOWALCZYS M,ABRAMCZYK P. A.. | 1 0.01 98.07 NEWTON R, KING D, LEE H, ANDERSON M A.. | 1 0.01 98.08 NIJHOF I, ZWEEGMAN S, LEVIN M, KOENE .. | 1 0.01 98.09 NISHIMURA, Y.. EXPERIENCE OF TRANSURE.. | 1 0.01 98.10 NONAKA F, OKAMOTO M, ARIMORI H, ET AL.. | 1 0.01 98.11 NONAKA Y,KATO M,TAKENAKA K,HITOMI W. .. | 2 0.02 98.13 NORIKO MATSUNAGA, ET AL.. REVIEW OF T.. | 1 0.01 98.14 NUDELMAN KN, WANG Y, MCDONALD BC, CON.. | 1 0.01 98.15 OCHI Y, HIRAMOTO N, TAKEGAWA H, YONET.. | 1 0.01 98.16 ODESANYA RU, AUDU MD, FWANGSHAK S. EV.. | 1 0.01 98.17 OKADA K, ENDO Y, MIYACHI Y, KOIKE Y, .. | 1 0.01 98.18 OKAMOTO S, OGAWA E, YOSHIZAWA A, OKAJ.. | 1 0.01 98.19 OKAWARA S, OOKAWARA S, MIYAZAWA H, IT.. | 1 0.01 98.20 OKUMURA N, KAWASAKI M, IMAI S. DESTRU.. | 1 0.01 98.21 OLIVER G. MCDONALD, MD, PHD. A COMPAR.. | 1 0.01 98.22 OLSSON EK, LEMBERG M. SEVERE PARACETA.. | 1 0.01 98.23 OLSSON RF, HAGELBERG S, SCHILLER B, R.. | 1 0.01 98.24 OMATSU K, OMATSU T, USAMI C, TANIGUCH.. | 1 0.01 98.25 OMURA Y, HARANAKA M, IMADA C, OZAKI T.. | 1 0.01 98.26 OOSTEN AW, ABRANTES JA, JONSSON S, BR.. | 1 0.01 98.27 OROZCO BS, GRAY III T, SETZER SC, COL.. | 1 0.01 98.28 OSHIRO S,ARAGAKI T,KUBA M,KANESHIRO Y.. | 1 0.01 98.29 OSTERHOUDT KC, TRELLA J, HENRETIG F. .. | 2 0.02 98.31 OUAHED J, THIAGARAJAH J, RUFO P, RIVK.. | 1 0.01 98.32 OZEKI T, FUJISHIMA K, TAKAHASHI T, NI.. | 1 0.01 98.33 OZGUN U, DEMET T, OZGE K, ZAFER D, MU.. | 1 0.01 98.34 OZPELIT E, BADAK O, EDEM E, OZPELIT M.. | 1 0.01 98.35 OZPELIT E, OZPELIT ME, AKDENIZ B, GOL.. | 1 0.01 98.36 PAGANO MB, HOBBS W, LINENBERGER M, DE.. | 1 0.01 98.37 PAGE CB, MOSTAFA A, SAIAO A, MEDLEY G.. | 1 0.01 98.38 PAL G, LIN MM, LAURENO R. ASTERIXIS: .. | 1 0.01 98.39 PALLAVI R, CHAUDHARI A. PROLONGED HEM.. | 1 0.01 98.40 PALLAVI R, CHAUDHARI A. PROLONGED HEM.. | 1 0.01 98.41 PARK W, HRYCAJ P, JEKA S, KOVALENKO V.. | 1 0.01 98.42 PARRISH C, MORRIS CT, WILLIAMS CD, CA.. | 1 0.01 98.43 PASCART T, DUCOULOMBIER V, ROQUETTE .. | 1 0.01 98.44 PATANE P, KRUMMENACHER T, RAO R. VALS.. | 1 0.01 98.45 PAULZEN M, GRUNDER G, ORLIKOWSKY T, G.. | 1 0.01 98.46 PE?A-IR?N A.. DRUG-INDUCED LIVER INJU.. | 1 0.01 98.47 PEREIRA M, FERREIRA L, HORTA A, ET AL.. | 1 0.01 98.48 PERRIN E, SEGUINEAU LD, MARSAUDON E... | 1 0.01 98.49 PHILLPOTTS S, TASH E, SEN S. GLUCOSE-.. | 1 0.01 98.50 PILAR TB, CRISTINA SP, ENRIQUE SC, .. | 1 0.01 98.51 PILLAI A, FORD R, CHENG N, SHAH A, NO.. | 1 0.01 98.52 PINTURAUD M, LANNOY D, CARTIGNY M, CU.. | 1 0.01 98.53 PIRCHER M, MLINERITSCH B, FRIDRIK MA,.. | 1 0.01 98.54 PLEYER L, BURGSTALLER S, STAUDER R, G.. | 1 0.01 98.55 POPA M. DRUG INCOMPATIBILITIES. GALEN.. | 1 0.01 98.56 PROSSER JM, JONES BE, NELSON L. COMPL.. | 1 0.01 98.57 PRUUNSILD C, ILISSON J. MACROPHAGE AC.. | 1 0.01 98.58 PUHALLA S, MROZEK E, YOUNG D, OTTMAN .. | 1 0.01 98.59 PUIG L, VERONICA R. LONG-TERM EFFICAC.. | 1 0.01 98.60 PUJADE-LAURAINE E, SELLE F, WEBER B, .. | 1 0.01 98.61 PUNGPAPONG S, WERNER KT, AQEL B, LEIS.. | 1 0.01 98.62 PUSHKAS M, ALBRIGHT J, SHAH D. ENALAP.. | 1 0.01 98.63 QUIDLEY AM, BOOKSTAVER PB, GAINEY AB,.. | 1 0.01 98.64 RADOSEVICH JJ, PATANWALA AE, ERSTAD B.. | 1 0.01 98.65 RAMIREZ G, CAPOTE F, CASANOVA M, RIOS.. | 1 0.01 98.66 REID RD. FLEXIBLE AND EXTENDED DOSING.. | 1 0.01 98.67 RENARD D, RUBLI E, VOIDE N, BORRUAT F.. | 1 0.01 98.68 REPORTER KNOWN TO LICENCEE. A STUDY O.. | 1 0.01 98.69 RIDER TG, GRACE RJ, NEWMAN JA. AUTOIM.. | 1 0.01 98.70 RIES T, SIEMONSEN S, GRZYSKA U, ZEUME.. | 1 0.01 98.71 RINI, B. I.. PHASE 1 DOSE-ESCALATION .. | 1 0.01 98.72 RINI, B.. PHASE 1 DOSE-ESCALATION TRI.. | 1 0.01 98.73 RINI, B.. PHASE 1 DOSE-ESCALATION TRI.. | 1 0.01 98.74 RINI, BRIAN I. PHASE 1 DOSE-ESCALATIO.. | 1 0.01 98.75 ROBSON Y, CHOWDHURY MM, SHORT E, ROWL.. | 1 0.01 98.76 RODGERS B, KUMAR A. RAPIDLY PROGRESSI.. | 1 0.01 98.77 ROSENBLOOM MH, FINLEY R, SCHEINMAN MM.. | 1 0.01 98.78 ROSENBLOOM MH, FINLEY R, SCHEINMAN MM.. | 1 0.01 98.79 RUBIO ALVARO N. SERIOUS QT INTERVAL P.. | 1 0.01 98.80 SACCHI S. SAFETY AND EFFICACY OF LENA.. | 1 0.01 98.81 SAKO A. RELATION BETWEEN STATUS OF US.. | 1 0.01 98.82 SANANI, S.. 5-FU CARDIOTOXICITY. CANC.. | 1 0.01 98.83 SATO A, ASAI S, KATO S, FURUYA T, MAE.. | 1 0.01 98.84 SATO H. 87 ONSET OF PRIMARY CENTRAL N.. | 1 0.01 98.85 SATOSKAR R, AHN J, TE HS, DEISING A, .. | 1 0.01 98.86 SCHLENK R, STEGELMANN F, ANDREAS R, J.. | 1 0.01 98.87 SCOTT B. PROLONGED RESPONSES IN PATIE.. | 1 0.01 98.88 SETHI R, KABLINGER AS, KAVURU B. SERO.. | 1 0.01 98.89 SETSU N, KOBAYASHI E, CHUMAN H, ET AL.. | 1 0.01 98.90 SEYMOUR JF, PFREUNDSCHUH M, TRNENY M,.. | 1 0.01 98.91 SHAH M, MADEO J, RAJAN D, RIZVON K, V.. | 1 0.01 98.92 SHARMA MP, KAR SK. SURREPTITIOUS METF.. | 3 0.03 98.95 SHEEN VL, OHAEGBULAM C, RENCUS T, TON.. | 1 0.01 98.96 SHIN T, GUERRERO AF. CALCIUM MAELSTRO.. | 1 0.01 98.97 SHIOTA M. CLINICAL USE EXPERIENCE WIT.. | 1 0.01 98.98 SIEWIERA K, KRUKOWSKA-JAROS J, GORCZY.. | 1 0.01 98.99 SINGH S, SANGARALINGHAM LR, HEIEN H, .. | 1 0.01 99.00 SMALL E; SANDEFUR BJ. ACUTE RENAL FAI.. | 1 0.01 99.01 SMOLLIN CG, PETRIE MS, KEARNEY T. CAR.. | 1 0.01 99.02 SNYDER M, ET AL.. SERTRALINE : RHABDO.. | 1 0.01 99.03 SNYDER M, KISH T. SERTRALINE-INDUCED .. | 1 0.01 99.04 SNYDER, M.. SERTRALINE-INDUCED RHABDO.. | 1 0.01 99.05 SONG G, GAO H, YUAN Z. EFFECT OF LEUP.. | 1 0.01 99.06 SONG Z, YUE D, WEI C, LU Y. ECG ANA.. | 1 0.01 99.07 SPERTINO J, FERRER AL, VILARRASA E, P.. | 1 0.01 99.08 SPUNT SL, IRVING H, FROST J, SENDER L.. | 1 0.01 99.09 STONE GW, CLAYTON T, DELIARGYRIS EN, .. | 1 0.01 99.10 STUER K, CLAES S. MANIA FOLLOWING THE.. | 2 0.02 99.12 SUNELA K, BARLUND M. IFOSFAMIDIN AIHE.. | 1 0.01 99.13 SWOBODA H, KOPEC K, KOWALSKI JM, D^OR.. | 1 0.01 99.14 SZTURZ P, ADAM Z, KREJCI M, KOUKALOVA.. | 1 0.01 99.15 TADA K, YASUNO T, ITO K, ABE Y, MIYAK.. | 1 0.01 99.16 TAKAHAMA T, TAKEDA M, NISHINA S, NAKA.. | 1 0.01 99.17 TAKAHAMA T. A CASE OF SEVERE CEREBRAL.. | 1 0.01 99.18 TAKAHASHI H, MATSUMOTO Y, SUEMATSU M... | 1 0.01 99.19 TAKANAMI H. A CASE WHICH RESULTED IN .. | 1 0.01 99.20 TAKEDA M,SAKAI K,OKAMOTO K,HAYASHI H,.. | 1 0.01 99.21 TAKEHARA K, MITSUTO I, KAWAI Y. A CAS.. | 1 0.01 99.22 TAKIZAWA T, KOHNO M, NISHIDA Y, YAGI .. | 1 0.01 99.23 TANABE Y,MATSUNO K,KOYAMA R,SATO T,TO.. | 1 0.01 99.24 TANAKA M,JIANG S,NAKASHIMA H,FUKUI T,.. | 1 0.01 99.25 TANIGAKI Y. THE 170TH MEETING OF JAPA.. | 1 0.01 99.26 TARKIAINEN M, TYNJALA P, VAHASALO P, .. | 1 0.01 99.27 TAU J,BATES J,CARUSO A. THE LOW SALT .. | 1 0.01 99.28 TERADA N, AKAMATSU S, OKADA Y, NEGORO.. | 1 0.01 99.29 TERADA N, AKAMATSU S, OKADA Y, NEGORO.. | 1 0.01 99.30 TERADA N, AKAMATSU S, OKADA Y, NEGORO.. | 6 0.06 99.36 THOMAS D, EMERY P, GREENWALD M, YIN D.. | 1 0.01 99.37 THOMAS F, HENNEBELLE I, DELMAS C, LOC.. | 1 0.01 99.38 THORNTON S,FARNAES L,MINNS A. PROLONG.. | 1 0.01 99.39 THORNTON SL, PCHELNIKOVA J, CANTRELL .. | 1 0.01 99.40 TOBE E. PSEUDODEMENTIA CAUSED BY SEVE.. | 1 0.01 99.41 TRAINA TA, KAUFMAN PA, CADOO KA, HUD.. | 1 0.01 99.42 TRAMADOL: RESPIRATORY DEPRESSION IN A.. | 1 0.01 99.43 TROENDLE MM, CUMPSTON KL, POWELL AO, .. | 1 0.01 99.44 TSUBOUCHI Y, ISODA Y.. A CASE OF THE .. | 1 0.01 99.45 TSUTAOKA B, HO R, KEARNEY T. TAPENTAD.. | 1 0.01 99.46 TZACHANIS D, HAIDER M, PAPAZISIS G. A.. | 1 0.01 99.47 UEDA S, SAKAYORI T, OMORI A, FUKUTA H.. | 1 0.01 99.48 UEDA S. NEUROLEPTIC-INDUCED DEFICIT S.. | 1 0.01 99.49 VALESHABAD, K, A.. POSTERIOR SEGMENT .. | 1 0.01 99.50 VALVO G, NOVARA F, BROVEDANI P, FERRA.. | 1 0.01 99.51 VERECKEI A, FAZAKAS A, BALO T, FEKETE.. | 1 0.01 99.52 VERMA R. CANAGLIFLOZIN-ASSOCIATED ACU.. | 1 0.01 99.53 VIJ R. A PHASE 1B DOSE ESCALATION TRI.. | 1 0.01 99.54 VILLANO J, LOVELL E. MIXED SIGNALS: T.. | 1 0.01 99.55 WAISER J, KNEBEL F, RUDOLPH B, WU K, .. | 1 0.01 99.56 WARREN RB, BROWN BC, LAVERY D, ASHCR.. | 1 0.01 99.57 WARRICK B, TATARU A, SMOLINSKE S. A S.. | 1 0.01 99.58 WATANABE H, SASAKI S, KAMIYAMA T, FUK.. | 1 0.01 99.59 WEERDT AD, SNOECKX A, GERMONPRE P, JO.. | 1 0.01 99.60 WEINER M, SARANTOPOULOS C, GORDON E. .. | 1 0.01 99.61 WEISS ET AL K. OUTCOME AND MANAGEMENT.. | 1 0.01 99.62 WEISS K. OUTCOME AND MANAGEMENT OF 20.. | 1 0.01 99.63 WENDELL L, MENKE N, KING A, WALLACE D.. | 1 0.01 99.64 WEST NA, SEVERTSON SG, GREEN JL, DART.. | 1 0.01 99.65 WHITNEY K, LAFOND A, RAMIREZ J. AZATH.. | 1 0.01 99.66 WIEGAND J, MAASOUMY B, BERG, WEDEMEYE.. | 1 0.01 99.67 WIEGAND TJ, GORODETSKY RM. RECREATION.. | 9 0.09 99.76 WILLIAMS P, CHONG D, FULLER T AND CAL.. | 1 0.01 99.77 WILLIAMS P, CHONG D, FULLER T AND CAL.. | 1 0.01 99.78 WILLIAMS P, CHONG D, FULLER T AND CAL.. | 1 0.01 99.79 WINQVIST M, MOZAFFARI F, PALMA M, SYL.. | 1 0.01 99.80 WU G, WU H, WU G. A COSTLY LESSON: FA.. | 1 0.01 99.81 YAGITA M, HAMANO T, HATACHI S, FUJIT.. | 1 0.01 99.82 YAGITA M, HAMANO T, HATACHI S, FUJITA.. | 1 0.01 99.83 YAMAGUCHI T,AKAO K,SOMA T,WATANABE T,.. | 1 0.01 99.84 YAMAMOTO H, ET AL.. A CASE OF ORAL MU.. | 1 0.01 99.85 YAMASHITA S, MIYAOKA T, NAGAHAMA M, I.. | 1 0.01 99.86 YAZAWA H, YOSHIDA Y, IKUMA D, ET AL. .. | 1 0.01 99.87 YEONG, T.T. NATURAL HISTORY AND OUTCO.. | 1 0.01 99.88 YEONG, T.T.. NATURAL HISTORY AND OUTC.. | 2 0.02 99.90 YIANNAKOPOULOU E. SERIOUS AND LONG-TE.. | 1 0.01 99.91 YILDIZ F, COBAN S. NECROTIC DERMAL LE.. | 1 0.01 99.92 YILMAZ-TOPAL O, TUYGUN N, AKCA H, POL.. | 1 0.01 99.93 YOO D, HRYCAJ P, MIRANDA P, RAMITERRE.. | 1 0.01 99.94 YOO DH, RACEWICZ A, BRZEZICKI J, YATS.. | 1 0.01 99.95 YOSHIDA H, TANIGUCHI H, NAKATA R. HEP.. | 1 0.01 99.96 YU X, ZHONG S, WANG P. ANALYSIS OF TH.. | 1 0.01 99.97 ZHANG X, LUCY R, SCOTT F, CAROL L, DE.. | 1 0.01 99.98 ZIVANOVIC-IVIC A, STAMATOVIC D, BALIN.. | 1 0.01 99.99 ZOLKIPLI Z, KIDMAN L, KEETON D, ERLEW.. | 1 0.01 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 6 Apr 2017